Source: International Congress 2016 – Systemic biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Keitaro Nakamoto (Tokyo, Japan), Keitaro Nakamoto, Masato Watanabe, Mitsuru Sada, Toshiya Inui, Yukari Ogawa, Masuo Nakamura, Kojiro Honda, Takashi Koide, Saori Takata, Takuma Yokoyama, Takeshi Saraya, Daisuke Kurai, Hiroo Wada, Haruyuki Ishii, Hajime Takizawa. Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma. Eur Respir J 2016; 48: Suppl. 60, 999

Member's Comments

No comment yet.

Related content which might interest you: Hydrogen sulphide as a biomarker in COPD and asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Oxidative stress and biomarkers in patients with bronchial asthma Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Assessment of serum magnesium level in patients with bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016 Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Various biomarkers of oxidative stress in patients with uncontrolled asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Exhaled breath temperature(EBT) in asthmatic patients: Influence of severity and underlying mechanisms Source: International Congress 2016 – Airway biomarkers Year: 2016 Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Exhaled breath condensate pH in assessment of childhood asthma control Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Evaluation of vitamin D in asthma: Its effect on inflammatory markers and clinical profile Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Associated factors with persistent airflow limitation in asthma in U-BIOPRED Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Calv,NO and J’awNO in asthma. A multidimensional approach Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015